Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Age- and Sex-Specific Risk Profiles and In-Hospital Mortality in 13,932 Spanish Stroke Patients.

Purroy F, Vena A, Forné C, de Arce AM, Dávalos A, Fuentes B, Arenillas JF, Krupinski J, Gómez-Choco M, Palomeras E, Martí-Fábregas J, Castillo J, Ustrell X, Tejada J, Masjuan J, Garcés M, Benabdelhak I, Serena J.

Cerebrovasc Dis. 2019;47(3-4):151-164. doi: 10.1159/000500205. Epub 2019 May 3.

PMID:
31055571
2.

Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.

Sánchez E, Betriu À, Yeramian A, Fernández E, Purroy F, Sánchez-de-la-Torre M, Pamplona R, Miquel E, Kerkeni M, Hernández C, Simó R, Lecube A; ILERVAS project; ILERVAS Project:, Hernández M, Rius F, Polanco D, Barbé F, Torres G, Suárez G, Portero-Otin M, Jové M, Colàs-Campàs L, Benabdelhak I, Farràs C, Ortega M, Manuel Valdivielso J, Bermúdez-López M, Martínez-Alonso M.

J Atheroscler Thromb. 2019 Mar 6. doi: 10.5551/jat.47498. [Epub ahead of print]

3.

Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project.

Sánchez E, Lecube A, Betriu À, Hernández C, López-Cano C, Gutiérrez-Carrasquilla L, Kerkeni M, Yeramian A, Purroy F, Pamplona R, Farràs C, Fernández E, Barbé F, Simó R; ILERVAS project, Hernández M, Rius F, Polanco D, de la Torre MS, Torres G, Godoy P, Portero-Otin M, Jové M, Colàs-Compàs L, Benabdelhak I, Miquel E, Ortega M, Valdivielso JM, Bermúdez M, Martínez-Alonso M.

Diabetes Metab. 2018 Apr 13. pii: S1262-3636(18)30079-X. doi: 10.1016/j.diabet.2018.04.002. [Epub ahead of print] No abstract available.

PMID:
29706471
4.

The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation.

Colàs-Campàs L, Royo JL, Montserrat MV, Marzo C, Molina-Seguín J, Benabdelhak I, Cambray S, Purroy F.

Pharmacogenomics J. 2018 Sep;18(5):652-656. doi: 10.1038/s41397-017-0007-z. Epub 2017 Dec 22.

PMID:
29273767
5.

Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia.

Cambray S, Portero-Otin M, Jové M, Torreguitart N, Colàs-Campàs L, Sanz A, Benabdelhak I, Yemisci M, Dalkara T, Dönmez-Demir B, Egea J, Purroy F.

Mol Neurobiol. 2018 Jul;55(7):6193-6200. doi: 10.1007/s12035-017-0827-5. Epub 2017 Dec 21.

PMID:
29270918
6.

Influence of Hospital Type on Outcomes of Individuals Aged 80 and Older with Stroke Treated Using Intravenous Thrombolysis.

Purroy F, Vena A, Cánovas D, Cardona P, Cocho D, Cuadrado-Godia E, Chamorro A, Dávalos A, Garcés M, Gomis M, Krupinski J, Palomeras E, Ribó M, Roquer J, Rubiera M, Sanahuja J, Saura J, Serena J, Ustrell X, Vargas M, Benabdelhak I, Abilleira S, Gallofré M; Catalan Stroke Code and Reperfusion Consortium.

J Am Geriatr Soc. 2017 Sep;65(9):E117-E122. doi: 10.1111/jgs.14935. Epub 2017 Jun 2.

PMID:
28574595
7.

A Current Estimation of the Early Risk of Stroke after Transient Ischemic Attack: A Systematic Review and Meta-Analysis of Recent Intervention Studies.

Valls J, Peiro-Chamarro M, Cambray S, Molina-Seguin J, Benabdelhak I, Purroy F.

Cerebrovasc Dis. 2017;43(1-2):90-98. doi: 10.1159/000452978. Epub 2016 Dec 20. Review.

PMID:
27992865
8.

Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients.

Purroy F, Cambray S, Mauri-Capdevila G, Jové M, Sanahuja J, Farré J, Benabdelhak I, Molina-Seguin J, Colàs-Campàs L, Begue R, Gil MI, Pamplona R, Portero-Otín M.

EBioMedicine. 2016 Dec;14:131-138. doi: 10.1016/j.ebiom.2016.11.010. Epub 2016 Nov 9.

9.

Clinical Evolution of Elderly Adults with Ischemic Stroke.

Vena AB, Cambray S, Molina-Seguin J, Colàs-Campàs L, Sanahuja J, Quílez A, González-Mingot C, Gil-Villar MP, Benabdelhak I, Mauri-Capdevila G, Purroy F.

J Am Geriatr Soc. 2016 Oct;64(10):2167-2170. doi: 10.1111/jgs.14426. Epub 2016 Aug 26. No abstract available.

PMID:
27564081
10.

The determination of copeptin levels helps management decisions among transient ischaemic attack patients.

Purroy F, Suárez-Luis I, Cambray S, Farré J, Benabdelhak I, Mauri-Capdevila G, Sanahuja J, Quílez A, Begué R, Gil MI, Molina-Seguin J, Torreguitart N.

Acta Neurol Scand. 2016 Aug;134(2):140-7. doi: 10.1111/ane.12523. Epub 2015 Oct 16.

PMID:
26471428
11.

Metabolomics predicts stroke recurrence after transient ischemic attack.

Jové M, Mauri-Capdevila G, Suárez I, Cambray S, Sanahuja J, Quílez A, Farré J, Benabdelhak I, Pamplona R, Portero-Otín M, Purroy F.

Neurology. 2015 Jan 6;84(1):36-45. doi: 10.1212/WNL.0000000000001093. Epub 2014 Dec 3.

12.

Prediction of myocardial infarction in patients with transient ischaemic attack.

Vilanova MB, Mauri-Capdevila G, Sanahuja J, Quilez A, Piñol-Ripoll G, Begué R, Gil MI, Codina-Barios MC, Benabdelhak I, Purroy F.

Acta Neurol Scand. 2015 Feb;131(2):111-9. doi: 10.1111/ane.12291. Epub 2014 Oct 10.

PMID:
25302931
13.

N-terminal pro-brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation.

Purroy F, Suárez-Luis I, Mauri-Capdevila G, Cambray S, Farré J, Sanahuja J, Piñol-Ripoll G, Quílez A, González-Mingot C, Begué R, Gil MI, Fernández E, Benabdelhak I.

Eur J Neurol. 2014 Apr;21(4):679-83. doi: 10.1111/ene.12222. Epub 2013 Jun 25.

PMID:
23800180

Supplemental Content

Loading ...
Support Center